LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $552,402 | -16.9% | 9,219 | 0.0% | 0.18% | -26.6% |
| Q2 2023 | $664,690 | -2.0% | 9,219 | 0.0% | 0.24% | +0.8% |
| Q1 2023 | $678,150 | +197.4% | 9,219 | +248.4% | 0.24% | +36.6% |
| Q3 2022 | $228,000 | +13.4% | 2,646 | +100.3% | 0.18% | +182.3% |
| Q1 2021 | $201,000 | -87.5% | 1,321 | -92.2% | 0.06% | -91.9% |
| Q3 2020 | $1,610,000 | -0.7% | 16,887 | +16.4% | 0.77% | -0.1% |
| Q2 2020 | $1,622,000 | +109.3% | 14,505 | +36.1% | 0.77% | +43.8% |
| Q1 2020 | $775,000 | -50.4% | 10,661 | -28.8% | 0.54% | +34.7% |
| Q4 2019 | $1,561,000 | – | 14,964 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |